The nation of Zimbabwe has declined a substantial US healthcare agreement worth $367m (£272m) spanning five years over the United States' demand for sensitive biological samples.
This rejection came to light after a internal memorandum from December was leaked, indicating that Head of State Emmerson Mnangagwa believed the deal was "unbalanced".
An official spokesman has since stated that the United States was demanding access to genetic material for scientific study and commercial purposes while refused to guarantee the resulting advantages from any future medical innovations.
"We will now turn to the difficult and regrettable task of ending our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had donated over $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has appealed for more dialogue to reach a agreement agreeable to both sides so the nation's vital HIV treatment initiative can continue.
Wider Background
Zimbabwe's decision follows a comparable case in neighbouring Kenya, where a high court suspended a similar deal with the US following legal challenges were raised about the safety of citizens' medical information.
Since returning to the presidency recently, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
USAID had administered assistance for the US government, but Trump claimed its expenditure was "wasteful" and his administration was seeking government-to-government deals to boost openness and responsibility.
Based on statements, Sixteen nations in Africa have so far agreed to similar health pacts, constituting more than $18.3bn in committed funds.
Details of the Declined Deal
The money for Zimbabwe would have supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this partnership might have yielded immense benefits for Zimbabwean communities, especially the 1.2 million presently on HIV treatment through US-supported programmes," Tremont commented.
However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".
"Zimbabwe was being asked to share its genetic material and health information over an extended period, with no equivalent promise of access to any medical innovations – like new medicines or tests – that might be developed from that shared data," he stated.
"Put simply, our nation would provide the raw materials for medical research with no certainty that the resulting innovations would be available to our population should a future health crisis emerge."
National Interest and International Frameworks
Mangwana further noted that the US's withdrawal from the global health body and its pursuit of bilateral deals were undermining frameworks already established via the global health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to manage future pandemics.
"This system is intended to ensure that when a country contributes its data, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "are not meant as opposition to America," Mangwana stressed.
"We encourage continued dialogue with our US partners on how subsequent co-operation could be designed in a manner that honours the independence and interests of each country."
Health Experts Reaction
A leading public health body expressed it understood the government's concerns, but recommended that negotiations must proceed considering a large portion of the country's Aids initiatives depended on international support.
"Where specific concerns arise, including those involving information security or implementation frameworks, these can often be resolved through detailed discussion and negotiated safeguards," the group commented.
The situation highlights the continuing challenges between receiving crucial international aid and safeguarding a country's data in an increasingly interconnected world.